{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:05:59Z","timestamp":1791223559207,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.intimp.2006.03.009","type":"journal-article","created":{"date-parts":[[2006,4,24]],"date-time":"2006-04-24T20:01:49Z","timestamp":1145908909000},"page":"1267-1276","source":"Crossref","is-referenced-by-count":19,"title":["The efficacy of CpG oligodinucleotides, in combination with conventional adjuvants, as immunological adjuvants to swine streptococcic septicemia vaccine in piglets in vivo"],"prefix":"10.1016","volume":"6","author":[{"given":"Zhang","family":"Linghua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xingshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Fengzhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2006.03.009_bib1","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0264-410X(00)00422-9","article-title":"Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid","volume":"19","author":"Eastcott","year":"2001","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.intimp.2006.03.009_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0264-410X(02)00169-X","article-title":"Mechanisms of stimulation of the immune response by aluminum adjuvants","volume":"20","author":"HogenEsch","year":"2002","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.intimp.2006.03.009_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/intimm\/9.4.523","article-title":"In vivo induction of type 1 and 2 immune responses against protein antigens","volume":"9","author":"Comoy","year":"1997","journal-title":"Int Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2006.03.009_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.intimp.2006.03.009_bib5","first-page":"636","article-title":"Ganglioside vaccines with emphasis on GM2","volume":"25","author":"Livingston","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1016\/j.intimp.2006.03.009_bib6","series-title":"Vaccine design: the subunit and adjuvant approach","first-page":"141","article-title":"A compendium of vaccine adjuvants and excipients","author":"Vogel","year":"1995"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2006.03.009_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0264-410X(02)00378-X","article-title":"CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein","volume":"21","author":"Ioannou","year":"2002","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.intimp.2006.03.009_bib8","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.1128\/JVI.76.18.9002-9010.2002","article-title":"The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides","volume":"76","author":"Ioannou","year":"2002","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.intimp.2006.03.009_bib9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen","volume":"160","author":"Davis","year":"1998","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2006.03.009_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0264-410X(98)00151-0","article-title":"CpG motifs as immune adjuvants","volume":"17","author":"Klinman","year":"1999","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.intimp.2006.03.009_bib11","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2006.03.009_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2006.03.009_bib13","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0264-410X(99)00526-5","article-title":"CpG DNA induces stronger immune responses with less toxicity than other adjuvants","volume":"18","author":"Weeratna","year":"2000","journal-title":"Vaccine"},{"issue":"27\u201328","key":"10.1016\/j.intimp.2006.03.009_bib14","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/S0264-410X(03)00437-7","article-title":"Safety and efficacy of CpGcontaining oligodeoxynucleotides as immunological adjuvants in rabbits","volume":"21","author":"Ioannou","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.intimp.2006.03.009_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0378-1135(00)00300-X","article-title":"Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides","volume":"78","author":"Kamstrup","year":"2001","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.intimp.2006.03.009_bib16","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1099\/vir.0.19362-0","article-title":"Identification of a sequence from the genome of porcine circovirus type 2 with an inhibitory effect on INFalpha production by porcine PBMCs","volume":"84","author":"Hasslung","year":"2003","journal-title":"Gen Virol"},{"key":"10.1016\/j.intimp.2006.03.009_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.vetimm.2004.12.020","article-title":"Porcine-specific CpG-oligodeoxynucleotide activates B-cells and increases the expression of MHC-II molecules on lymphocytes","volume":"105","author":"Van der Stede","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"issue":"6","key":"10.1016\/j.intimp.2006.03.009_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.dci.2005.07.005","article-title":"Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo","volume":"30","author":"Zhang","year":"2006","journal-title":"Dev Comp Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2006.03.009_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.intimp.2005.08.018","article-title":"CpG oligodinucleotides induce strong humoral and cellular responses to swine streptococcic septicemia vaccine in piglets in vivo","volume":"6","author":"Zhang","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2006.03.009_bib20","doi-asserted-by":"crossref","first-page":"10214","DOI":"10.1128\/JVI.73.12.10214-10223.1999","article-title":"Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response","volume":"73","author":"Lewis","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.intimp.2006.03.009_bib21","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1292\/jvms.62.995","article-title":"In vivo and in vitro tests showing sensitization to Japanese cedar (Cryptomeria japonica) pollen allergen in atopic dogs","volume":"62","author":"Masuda","year":"2000","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.intimp.2006.03.009_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.intimp.2006.03.009_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.intimp.2006.03.009_bib24","series-title":"Proceedings of the second international symposium on activating immunity with CpG oligos, Amelia Island, FL","article-title":"CpG ODN is generally well tolerated and highly effective in humans as adjuvant to HBV vaccine: preliminary results of phase 1 trial with CpG ODN 7909","author":"Davis","year":"2001"},{"key":"10.1016\/j.intimp.2006.03.009_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2006.03.009_bib26","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1084\/jem.168.6.2373","article-title":"Virally induced modulation of murine IgG antibody subclasses","volume":"168","author":"Coutelier","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2006.03.009_bib27","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4049\/jimmunol.147.4.1383","article-title":"IgG subclass distribution of primary and secondary immune responses concomitant with viral infection","volume":"147","author":"Coutelier","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2006.03.009_bib28","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-\u03b3 and B cell stimulatory factor-1 reciprocally regulate Ig isotype production","volume":"236","author":"Snapper","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.intimp.2006.03.009_bib29","series-title":"Fundamental immunology","first-page":"831","article-title":"Immunoglobulin class switching","author":"Snapper","year":"1998"},{"key":"10.1016\/j.intimp.2006.03.009_bib30","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.4049\/jimmunol.153.11.4948","article-title":"Regulation of human IgG subclass production by cytokines","volume":"153","author":"Kawano","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2006.03.009_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-2427(96)05684-X","article-title":"Differentiation of B cells in the bovine. Role of cytokines in immunoglobulin isotype expression","volume":"54","author":"Estes","year":"1996","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.intimp.2006.03.009_bib32","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2006.03.009_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000024303","article-title":"CpG DNA as a Th1 trigger","volume":"121","author":"Heeg","year":"2000","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.intimp.2006.03.009_bib34","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/S0264-410X(02)00216-5","article-title":"CpG containing oligodeoxynucleotides augment and switch immune responses of cattle to bovine herpesvirus-1","volume":"20","author":"Rankin","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2006.03.009_bib35","series-title":"Immunological adjuvants and vaccine","first-page":"35","article-title":"Aluminium salts: perspectives in their use as adjuvants","author":"Bomford","year":"1989"},{"key":"10.1016\/j.intimp.2006.03.009_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/biol.1994.1008","article-title":"Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid","volume":"22","author":"Gupta","year":"1994","journal-title":"Biologicals"},{"key":"10.1016\/j.intimp.2006.03.009_bib37","first-page":"20","article-title":"Adult immunization: preparation and evaluation of combined fluid tetanus and diphtheria toxoids for adult use","volume":"73","author":"Levine","year":"1961","journal-title":"Am J Hyg"},{"key":"10.1016\/j.intimp.2006.03.009_bib38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1056\/NEJM196601272740404","article-title":"Active\u2013passive tetanus immunization","volume":"274","author":"Levine","year":"1966","journal-title":"N Eng J Med"},{"key":"10.1016\/j.intimp.2006.03.009_bib39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1699-0463.1988.tb05299.x","article-title":"On the effect of Al(OH)3 as an immunological adjuvant","volume":"96","author":"Jensen","year":"1988","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"issue":"8","key":"10.1016\/j.intimp.2006.03.009_bib40","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/IAI.67.8.3719-3726.1999","article-title":"Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major","volume":"67","author":"Stacey","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.intimp.2006.03.009_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1440-1711.2003.01135.x","article-title":"CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB\/c mice","volume":"81","author":"Weeratna","year":"2003","journal-title":"Immunol Cell Biol"},{"issue":"13","key":"10.1016\/j.intimp.2006.03.009_bib42","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1089\/10430349950017086","article-title":"CpG: the double-edged sword","volume":"10","author":"Paillard","year":"1999","journal-title":"Hum Gene Ther"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2006.03.009_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vetimm.2003.10.001","article-title":"In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep","volume":"98","author":"Nichani","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.intimp.2006.03.009_bib44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cellimm.2004.01.004","article-title":"CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep","volume":"227","author":"Nichani","year":"2004","journal-title":"Cell Immunol"},{"key":"10.1016\/j.intimp.2006.03.009_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants \u2014 a classification and review of their modes of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2006.03.009_bib46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/jlb.67.2.226","article-title":"Particulate adjutants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM-CSF and CSF-1","volume":"67","author":"Hamilton","year":"2000","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.intimp.2006.03.009_bib47","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/IAI.69.2.1151-1159.2001","article-title":"The common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism","volume":"69","author":"Ulanova","year":"2001","journal-title":"Infect Immun"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576906000968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576906000968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T05:29:44Z","timestamp":1683437384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576906000968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S1567576906000968"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2006.03.009","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}